Retinal microvascular changes in patients with ankylosing spondylitis receiving biologic therapy: a cross-sectional OCTA study

Basit Öğe Kaydı
dc.contributor.authorSamanci, Rumeysa
dc.contributor.authorMeydan, Bayram
dc.contributor.authorTeberik, Kuddusi
dc.contributor.authorMeydan, Sumeyye Ucar
dc.contributor.authorAtaoglu, Safinaz
dc.date.accessioned2026-07-01T11:39:39Z
dc.date.available2026-07-01T11:39:39Z
dc.date.issued2026
dc.departmentDüzce Üniversitesi
dc.description.abstractBackground To evaluate retinal microcirculation in biologic-treated ankylosing spondylitis (AS) using optical coherence tomography angiography (OCTA) and its association with disease activity. Methods Fifty-seven AS patients (31 active, 26 inactive) under biologic therapy and 57 age- and sex-matched healthy controls were included. Right eyes underwent 10 degrees & times;10 degrees macular OCTA imaging (Heidelberg Spectralis). Vessel area density (VAD), foveal avascular zone (FAZ) metrics, and vessel density within a 300-& micro;m-wide ring surrounding the FAZ (FD-300) were quantified for the superficial and deep vascular complexes (SVC and DVC). Structural OCT provided foveal and parafoveal retinal thickness, peripapillary retinal nerve fiber layer (RNFL), and subfoveal choroidal thickness. Biologic therapy details and disease activity indices (Ankylosing Spondylitis Disease Activity Score-C-reactive protein [ASDAS-CRP], Bath Ankylosing Spondylitis Disease Activity Index [BASDAI], Bath Ankylosing Spondylitis Functional Index [BASFI]) were obtained from records. OCTA and structural parameters were compared among active AS, inactive AS, and control groups. Results Parafoveal SVC VAD was reduced only in the active AS group (p = 0.007), whereas DVC total/parafoveal VAD and FD-300 values were lower in both AS groups compared with controls (all p < 0.01). Retinal thickness, RNFL, and choroidal thickness were similar across groups (all p > 0.05). For distinguishing AS patients from controls, DVC metrics showed the highest performance (AUC approximate to 0.70-0.73; 0.63 for SVC), while the combined model including age, sex, and OCTA parameters achieved an AUC of 0.77. For differentiating disease activity, DVC-FAZ alone showed limited performance (AUC = 0.67). A parsimonious multivariable model including age, sex, BASFI, and DVC FAZ area yielded an AUC of 0.88 (95% CI: 0.80-0.97). Conclusions In AS patients receiving biologic therapy, retinal microcirculatory alterations were detected-particularly within the DVC-while retinal and choroidal structural measurements appeared to remain largely preserved. Further studies are warranted to confirm these findings.
dc.identifier.doi10.1186/s12886-026-04866-x
dc.identifier.issn1471-2415
dc.identifier.issue1
dc.identifier.orcid0000-0002-7752-6516
dc.identifier.pmid42062959
dc.identifier.scopus2-s2.0-105041945678
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1186/s12886-026-04866-x
dc.identifier.urihttps://hdl.handle.net/20.500.12684/23400
dc.identifier.volume26
dc.identifier.wosWOS:001795658100001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBmc
dc.relation.ispartofBmc Ophthalmology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20260623
dc.subject[Keyword Not Available]
dc.titleRetinal microvascular changes in patients with ankylosing spondylitis receiving biologic therapy: a cross-sectional OCTA study
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu